TRT and Fertility: What You Need to Know

Testosterone replacement therapy is highly effective at restoring testosterone levels and improving the quality of life for men with hypogonadism. But there is a critical trade-off that every man considering TRT should understand before starting: exogenous testosterone suppresses the body’s own sperm production. For men who are not planning to have children, this is largely a non-issue. For men who want to preserve their fertility, either now or in the future, it is a central consideration that should shape treatment decisions from the outset. This article explains exactly why TRT affects fertility, what the research shows about recovery, and what alternatives exist for men who want to address low testosterone without compromising reproductive potential. For more on what TRT involves, see our overview of testosterone replacement therapy.

Why TRT Suppresses Sperm Production

Sperm production (spermatogenesis) depends on a specific hormonal environment within the testes. The key signals are luteinizing hormone (LH) and follicle-stimulating hormone (FSH), both released by the pituitary gland in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus. LH stimulates testosterone production in Leydig cells; FSH directly stimulates Sertoli cells, which support and nourish developing sperm cells ( 1 ).

When exogenous testosterone is administered, the hypothalamus detects adequate levels of testosterone in the blood and reduces its GnRH output. This in turn reduces pituitary LH and FSH secretion. Without adequate LH and FSH signaling, both intratesticular testosterone (which is much higher than serum testosterone and essential for spermatogenesis) and Sertoli cell function decline. The result is dramatically reduced or absent sperm production ( 2 ).

This is not a side effect in the incidental sense. It is a predictable consequence of the HPG axis feedback loop that governs reproductive hormones. Men on TRT are, in effect, chemically suppressing the hormonal environment that spermatogenesis requires.

How Long Does It Take for Fertility to Be Affected?

Significant reduction in sperm count typically occurs within weeks to months of starting TRT. Studies using testosterone as a method of male contraception have shown that sperm counts fall to very low or undetectable levels within three to four months in the majority of men ( 1 ). For some men, this occurs faster; for others, a small amount of residual spermatogenesis may persist.

The rapidity and completeness of suppression varies by individual, delivery method, and dose. What is consistent is the direction of effect: TRT suppresses sperm production, and men who are not monitoring fertility status on TRT may not know the extent of suppression unless they undergo semen analysis.

Does Fertility Return After Stopping TRT?

For most men, sperm production does recover after discontinuing TRT, but recovery is neither immediate nor guaranteed. Research suggests that the majority of men recover sperm production within six to eighteen months of stopping TRT, with some studies showing median recovery times of around six months ( 2 ), ( 3 ). However, recovery is not universal. A subset of men, particularly those who have used TRT for many years, experience incomplete recovery or prolonged suppression.

Age, duration of TRT use, pre-treatment fertility status, and the presence of other fertility-affecting conditions all influence recovery. Men who had borderline semen parameters before starting TRT, or who have a primary testicular issue (as opposed to secondary hypogonadism), may have a more difficult recovery.

Alternatives to TRT for Men Who Want to Preserve Fertility

For men with hypogonadism who want to preserve fertility, two primary alternatives to standard TRT exist:

Clomiphene Citrate

Clomiphene citrate is a selective estrogen receptor modulator (SERM) originally developed for female fertility treatment. In men, it blocks estrogen receptors in the hypothalamus, which normally provide negative feedback to reduce GnRH and LH secretion. By blocking this feedback, clomiphene increases GnRH pulsatility, raising LH and FSH, which in turn stimulate both testosterone and sperm production. Because the HPG axis remains active, spermatogenesis is maintained or improved rather than suppressed ( 3 ).

Clomiphene does not work for all forms of hypogonadism. It is most effective for secondary (central) hypogonadism where the HPG axis is functional but under-stimulated. Men with primary testicular failure (where the testes themselves are the problem) will not respond as well.

Human Chorionic Gonadotropin (hCG)

hCG mimics the action of LH, directly stimulating Leydig cells in the testes to produce testosterone. Unlike exogenous testosterone, hCG preserves the intratesticular testosterone levels needed for spermatogenesis. It can be used alone as an alternative to TRT or in combination with TRT (particularly testosterone cypionate) to maintain testicular function and sperm production in men on TRT who want to keep fertility options open ( 2 ).

hCG combined with TRT does not fully normalize sperm counts in all cases, but it significantly reduces the degree of suppression compared to TRT alone. For men who are on TRT but discover they want to attempt conception, hCG can be used as a bridge to stimulate testicular recovery.

Sperm Banking: A Practical Consideration

For any man with low testosterone who wants to preserve future fertility options and is considering TRT, sperm cryopreservation (banking) before starting treatment is a practical step worth discussing with a fertility specialist. Banked sperm provides an insurance policy: even if TRT suppresses sperm production during treatment, viable sperm are preserved for future use in assisted reproductive procedures.

Common Myths About TRT and Fertility

A widespread myth is that TRT is reversible, so fertility concerns can be addressed later. While most men do recover sperm production after stopping TRT, recovery is not guaranteed, takes time, and is not complete in all men. Treating fertility preservation as an afterthought increases the risk of a difficult or impossible recovery when fertility becomes important.

Another misconception is that natural testosterone levels and fertility are always linked: that is, a man with low testosterone always has low fertility. This is not accurate. Testosterone deficiency can occur with normal or even above-average sperm production if FSH and intratesticular testosterone are maintained. Conversely, TRT can normalize serum testosterone while simultaneously eliminating fertility.

When to See a Provider

Any man with low testosterone who is considering TRT and has not definitively ruled out future fatherhood should have a conversation with both a men’s health provider and ideally a reproductive urologist or fertility specialist before starting treatment. Semen analysis prior to TRT gives useful baseline information and informs the urgency of sperm banking or alternative treatment.

If you are currently on TRT and discover you want to attempt conception, speak with a provider about transition strategies. Do not stop TRT abruptly without medical guidance. If you are experiencing symptoms consistent with low testosterone, speaking with a men’s health provider is the right first step, with fertility considerations discussed openly as part of that evaluation.

Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

References

  1. Nieschlag E, Behre HM, Nieschlag S. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012.
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://doi.org/10.1210/jc.2018-00229
  3. Ko EY, Siddiqi K, Brannigan RE, Sabanegh ES. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol. 2012;187(3):973-978. https://doi.org/10.1016/j.juro.2011.10.137
  4. Meacham RB, Joyce GF, Wise M, et al. Male infertility. J Urol. 2007;177(6):2058-2066. https://doi.org/10.1016/j.juro.2007.01.131
  5. Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. https://doi.org/10.1016/j.juro.2012.09.043
  6. Wenker EP, Dupree JM, Langille GM, et al. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. J Sex Med. 2015;12(6):1334-1337. https://doi.org/10.1111/jsm.12890